To be able to describe the differences between the normal and tumor tissues of gastric cancer at a molecular level would be essential in the study of the disease. We investigated the gene expression pattern in the two types of tissues from gastric cancer by performing expression profiling of 86 tissues on 17K complementary DNA microarrays. To select for the differentially expressed genes, class prediction algorithm was employed. For predictor selection, samples were first divided into a training (n = 58), and a test set (n = 28). A group of 894 genes was selected by a t-test in a training set, which was used for cross-validation in the training set and class (normal or tumor) prediction in the test set. Smaller groups of 894 genes were individually tested for their ability to correctly predict the normal or tumor samples based on gene expression pattern. The expression ratios of the 5 genes chosen from microarray data can be validated by real time RT-PCR over 6 tissue samples, resulting in a high level of correlation, individually or combined. When a representative predictor set of 92 genes was examined, pathways of 'focal adhesion' (with gene components of THBS2, PDGFD, MAPK1, COL1A2, COL6A3), 'ECM-receptor interaction' pathway (THBS2, COL1A2, COL6A3, FN1) and 'TGF-beta signaling' (THBS2, MAPK1, INHBA) represent some of the main differences between normal and tumor of gastric cancer at a molecular level.
Introduction
Gastric cancer is the second-most-common cause of cancerrelated mortalities [1] . Traditionally, clinico-pathological factors have been used most frequently and are still important in assessing the prognosis of gastric cancer, albeit with limited applicability [2] . Therefore, the need exists for more objective molecular approaches in the assessment of gastric carcinogenesis and prognosis. Recent applications of genomic tools have produced a vast amount of information on the differential gene expression patterns related with gastric cancer. These include oligonucleotide or cDNA microarray-based gene expression profiling of the gastric carcinoma cell lines [3] , identification of the gastric cancer metastasis-related genes [4, 5] and the selection of the differentially expressed gene sets that can distinguish between normal and cancerous gastric tissues, or between the subtypes of gastric cancer [6] [7] [8] [9] [10] .
Class prediction is a powerful statistical tool that has been successfully applied to the microarray-based cancer genomics research. It is a process of assigning a particular test sample to among the pre-determined classes based on the similarity to expression profiles of samples in the training set. In a systematic approach to cancer classification and prediction, Golub et al. reported that DNA microarray-based gene expression information from a training set could be used to select a subset of genes (class predictor), which can classify the two different types of acute leukemias [11] . Tay et al. also used a similar system to accurately predict the subtype of an unknown gastric tumor sample [9] . In this report, using 86 gastric tissues that were allocated into a training set and a test set, the predictor gene sets were selected and the classifier was developed in the training set and the efficiency in the discrimination of normal versus tumor tissues was measured in the test set. The selected genes will help to explain the nature of molecular changes between normal and tumor tissues of gastric cancer.
Materials and methods

Tissue samples and RNA extraction
All experiments using the patient tissues were performed with approval from the Internal Review Board of Yonsei University College of Medicine. Tissues from the patients who underwent surgery at the Yonsei University College of Medicine during 1997-1999 were used. Tissues that contained at least 70% tumor content were used. The tissue samples (n = 86) were divided into a training set of 29 pairs (29 normal tissues and 29 matching tumor tissues, n = 58) and a test set of 28 samples (7 pairs, 8 non-paired normal tissues and 6 non-paired tumor tissues). 'Normal' refers to histologically normal gastric tissues and 'tumor' refers to gastric adenocarcinomas. The total RNA was extracted from the homogenized tissues using TRIzol (Invitrogen, Carlsberg, CA) reagent according to the manufacturer's protocol, and was further purified using RNeasy Mini Kit (Qiagen, Valencia, CA).
cDNA microarray and hybridization
Gene expression profilings were performed on cDNA microarrays containing 17,000 human probes. These microarrays have been successfully used in a number of projects before [12] [13] [14] [15] [16] [17] , producing reliable results. Polymerase chain reaction (PCR) products from Ultimate™ ORF Clones (Resgen/Invitrogen, Carlsbad, CA) were used to manufacture human 17K cDNA microarrays (GenomicTree, Daejeon, Korea). OmniGridTM Microarrayer (GeneMachines, Inc., San Carlos, CA) was used for printing PCR products onto a silanized glass slide surface (CMT-GAPSTM, Corning, Charlotte, NC). These 17,000 genes represent sequence-verified clones by the manufacturer. Of these, about 10,000 were function-annotated clones and the rest were CGAP (Cancer Genome Anatomy Project, NCI, USA) clones. The microarray hybridization was performed in an indirect-design; each of the cDNA targets generated from tissue total RNAs (Cy5-labeled) were competitively hybridized with cDNAs generated from the common reference RNA pool (Cy3-labeled) in each of the hybridization following a published protocols [18] . Common reference RNA, which is biologically irrelevant to the samples being analyzed and only functions to provide a denominator in ratios in cDNA microarrays, was prepared by pooling equivalent amount of total RNAs from the following cell lines; AGS, MDA-MB231, HCT 116, SK-HEP-1, A-549, HL-60, MOLT-4, HeLa, Caki-2, U-87MG, SK-MEL-2 and Capan-2 [12] . Hybridized slides were washed and then scanned using a Gene Pix 4000B laser scanner (Axon Instrument Inc, Union City, CA). The data were saved in a Gene Pix Result (GPR) format.
Microarray data analysis
Raw data normalization, gene filtering, classifier gene selection, crossvalidation for the training set and the class prediction for the test and independent sets were performed using GeneSpring 7.0 software (Silicon Genetics, Redwood City, CA). The raw data were print-tip normalized using the lowess function prior to gene filtering. Poor signals (signals not more than 1.5-fold higher than background signal in either of the Cy3 or Cy5) were removed from further analysis. Genes with Cy5/Cy3 ratios missing in at least one sample were also removed. The reliable genes were obtained by filtering the data by control strength-based elimination of the genes with a low control spot signal using the 'cross-gene error model' function in Gene Spring (12,891 genes remaining). A paired t-test was performed to select the differentially expressed genes between normal and tumor tissue groups (894 genes, p b 0.05). The Westfall and Young permutation-based multiple testing correction of the pvalues was used to minimize the occurrence of false positives. Two class prediction functions, k-nearest neighbor classification rule (k = 14) and support vector machine, were used for the prediction. To accomplish this, 894 genes were subjected to cross-validation in the training set. This procedure generated the prediction strengths (negative natural log of the p-value) for all of the 894 genes. The prediction strengths were evaluated for all genes on the selected gene list using the samples and their gene expression data in the training set. All genes were evaluated independently and ranked according to their power to discriminate each class from the others using the information from that gene alone. The 894 genes were then grouped based on the prediction strengths. In this system, each gene calculates the probability of obtaining an observed number of samples from each class (normal or tumor) above and below the "idealized expression pattern" [11] . Instead of using random small numbers, gene numbers based on the prediction strength were used as selection criteria for a smaller number of genes from the 894 genes (Table 1) . A full dataset of gene expression ratios of 17,000 genes and 86 patient tissues can be accessed at the web site of Cancer Metastasis Research Center (http://cmrc.yonsei.ac.kr/) with permission. Probes with unique Genbank accession numbers were counted as individual genes for current analysis.
Quantitative real-time reverse transcription-PCR
To confirm the microarray data with real-time RT-PCR, 3 pairs of gastric tissues (3 normal and 3 tumor) from the training set were randomly chosen and their expression levels were measured. The reaction was carried out in a total volume of 20 μl, which included 10 μl of QuantiTect SYBR Green PCR mixture containing 2.5 mM MgCl2 (Qiagen, CA), 2 μl of the cDNA and 20 pmol of oligonucleotide primers. PCR was performed at 95°C for 15 min in order to activate the HotstarTaq DNA polymerase, and then for 35 cycles of amplification at 95°C for 20s, 50°C for 30s, 72°C for 45 s on a Rotor Gene a The specific numbers of predictor genes were determined based on the prediction strength, and that number of genes was put into the gene selection algorithms of signal-to-noise or Fisher's exact test function to perform the crossvalidation or prediction in the GeneSpring.
b The gene numbers are accumulative from the highest prediction strength. For example, the 34 genes with a prediction strength of 34.5, contain 10 genes with prediction strength of 37.9 and 24 additional genes.
c Between gene numbers of 358 and 894, there were many groups of prediction strengths and not all of them are shown here.
2072D real-time PCR machine (Corbett Research, Sydney, Australia). The amplified fluorescence signal in each specimen was measured at the late extension step of each cycle. In order to quantify the signals from each gene, we used 10-fold serially diluted human genomic DNA as a control. The following oligonucleotide primers were used; 5′-gatacgacactgtccaggtt-3′ (forward) and 5′-ccagttcagacttccagtgt-3′ (reverse) for PGA5, 5′-tctgttcaaaacatgttcca-3′ and 5′-tgtggtaaataagattgggg-3′ for LIPF, 5′-acgaggacatagatgacgac-3′ and 5′-tttacaaatatcaccccgtc-3′ for THBS2, 5′-agctcacctatttgcatcat-3′ and 5′-ctctgtaattgcgacatgaa-3′ for REP15, 5′-gagaggggctgggcta-3′ and 5′-attcaaacaacagagccg-3′ for PARP10, and 5′-gggaattcaaaactggaacggtgaagg-3′ and 5′-ggaagcttatcaaagtcctcggccaca-3′ for β-Actin.
Results
Selection of the class predictors, cross-validation in the training set and tissue type prediction in the test set
The t-test between the tissue types (normal or tumor) in the training set resulted in the selection of 894 genes out of 12,891 at adjusted p b 0.05. The cross-validation with the 894 genes showed that the tissue types of all of the 58 samples in the training set were correctly predicted ( Table 1 ). The same set of 894 genes was then used to predict the tissue types in the test set. Twenty-seven of the 28 samples (96.4%) in the test set were correctly predicted. The cross-validation and prediction process resulted in the ranking of the 894 genes according to the prediction strength (a negative natural log of p-values, Materials and methods) of each gene. The subsets of the 894 genes were then formed based on the prediction strength (Table 1) , and were used for cross-validation in the training set and for prediction in the test set. The prediction efficiency for the test set remained the same at 96.4% from 894 genes down to 10 genes. In order to visualize the relative expression pattern of the predictor genes in both tissue types, a two-way hierarchical clustering of the representative set of 92 genes in the training set was performed (Fig. 1) . The detailed information about the 92 Fig. 1 . Expression pattern of predictor gene set. The expression ratios for the 92 genes in the 58 training set were subjected to a two-way hierarchical clustering and the result was shown as a heatmap. An enlarged view of the sample clustering is shown vertically, in the middle, each tissue sample being labeled with a unique number followed by N (normal) or T (tumor). A scale bar representing the relationship between the color intensity and gene expression log ratios is also shown. A detailed information including Genbank accession numbers, gene names and ratios for the 92 genes is in Table 2 . genes, including accession numbers, gene symbols, full names and average expression ratios in normal and tumor tissues, is described in Table 2 .
An identical sample labeled Y-GC-01-049 was incorrectly predicted as a normal. Tissues, Y-GC-01-049 and Y-GC-01-048, were originally given for the hybridization as a tumor and a normal tissue, respectively, originated from one patient. The reason for the incorrect prediction in the test set could be due to either an imperfect prediction algorithm or a technical mix-up during sample handling. Both of the Y-GC-01-048 and Y-GC-01-049 were subjected to haematoxylin and eosin (H&E) staining in order to clarify the ambiguity. H&E staining confirmed that the Y-GC-01-048 is a normal gastric tissue with gastritis. The Y-GC-01-049, which was labeled as a tumor, but was predicted to be normal by expression profiling-based prediction, was confirmed as a normal (Fig. 2) , showing that the class prediction algorithm can correctly identify the tissue types based only on the gene expression profiles. Based on this confirmation, the selected gene set can function as a predictor gene set that can successfully distinguish between normal and tumor tissues of gastric cancer.
Confirmation of the gene expression pattern by real-time RT-PCR
We tested if the differential expression pattern of the predictor genes could be recapitulated using real-time RT-PCR. For this 5 genes were selected from Table 1 , including Pepsinogen 5 (PGA5), Lipase, gastric (LIPF), Thrombospondin 2 (THBS2), Rab15 effector protein (REP15) and Poly (ADP-ribose) polymerase family, member 10 (PARP10). The ratios of each gene to control Actin beta were measured using total RNAs from 3 normal tissues and 3 tumor tissues, which were also used for gene expression profiling. The expression ratios of each gene in 6 tissues measured by real time RT-PCR and microarray experiments were then compared by way of Pearson's correlation. Higher correlations (R2 N 0.9) between expression ratios measured by microarray and RT-PCR over 6 tissues were observed for PGA5, LIPF, THBS2 and REP15 (Fig. 3) . A rather low correlation was observed for PARP10. Excluding PARP10, a combined analysis for expression ratios of 4 genes between microarray and RT-PCR also resulted in high correlation (R2 = 0.9199), while the presence of PARP10 in the combined analysis led to R2 value of 0.69. 'GB acc' refers to the Genbank accession number. 'N' and 'T' refer to average gene expression ratios from normal (n = 28) and tumor (n = 28) samples in the training set, respectively, and 'T/N' is the gene expression ratio in tumor tissues over normal tissues. The information on the gene names, gene symbols and cytoband information was from SOURCE [23] . Ninety-two genes (probes) are those containing unique GB acc. Some genes have more than 2 GB acc. For example, there are 2 probes for Aldo-keto reductase family 1, member B10 (AKR1B10), Calpain 9 (CAPN9), Aldehyde dehydrogenase 3 family, memberA1 (ALDH3A1) and Thy-1 cell surface antigen (THY1). The probe with accession number #AI611214 has been retracted from the public data base from the initial submission of this manuscript. Therefore, this table represents information for 85 non-redundant genes.
Molecular pathways representing the differences between normal and tumor tissues of gastric cancer
To interpret the function of the selected genes in a biologically meaningful manner, the 92 genes were subjected to pathway analysis. Five KEGG (Kyoto Encyclopedia of Genes and Genomes) molecular pathways represent the function of 92 genes. These include Thrombospondin 2 (THBS2), Platelet derived growth factor D (PDGFD), Mitogen-activated protein kinase 1 (MAPK1), Collagen, type I, alpha 2 (COL1A2), Collagen, type VI, alpha 3 (COL6A3) of the 'focal adhesion' pathway that is involved in cell-cell communication. The 'ECM-receptor interaction' pathway, involved in the processing of the cell signaling, represents THBS2, COL1A2, COL6A3 and Fibronectin 1 (FN1). The 'TGF-beta signaling' is one of the major signal transduction pathways and contains THBS2, MAPK1 and Inhibin beta A (INHBA) of the 92 genes. Two of the human disease pathways, 'colorectal cancer' and 'prion disease', are collection of genes known to be involved in human diseases, and represent PDGFD, MAPK1 and Nuclear factor (erythroidderived 2)-like 2 (NFE2L2), respectively, in the 92-gene set.
Discussion
Major efforts are being made to develop molecular signaturebased methods to complement the traditional histopathological diagnosis in gastric cancer and also to understand gastric cancer at a molecular level. Inoue et al. performed expression profiling on gastric tissues from 43 patients to build a prognostic scoring system that can aid in the understanding of the malignant behavior of the gastric tumors [19] . Hasegawa et al. looked into the intestinal-type gastric tissues obtained by laser-capture microdissection and identified genes differentially expressed in intestinal-type cancer and in lymph node metastasis [20] . Hippo et al. identified differential gene expression patterns between 22 gastric cancers and 8 non-cancerous tissues using oligonucleotide microarrays containing 6800 genes [7] . In a larger scale expression profiling, Boussioustas et al. identified genes differentially expressed between histological subtypes of tumors and pre-malignant gastric mucosa [8] . There also has been a study to correlate genetic aberrations and gene expression profiling [9] , and Chen et al. identified genes whose expression levels were significantly correlated with patient survival [10] .
Our study is distinguished from the previous studies in that a relatively large number of samples and genes were used for the expression profiling and class prediction algorithm is used in the assessment of the selected genes. We focused our attention in this study to the molecular differences between normal and tumor phenotypes of gastric cancer. Supervised learning classifications have been largely performed by the three algorithms; weighted voting [11] , k-nearest neighbors (k-NN) [21] and support vector machine (SVM) [22] . We employed k-NN classification algorithm as a prediction method in this report. To eliminate the possibility that the current result is due to a possible bias by an algorithm used in this specific case, we also tried SVM as a prediction algorithm using 92 genes. The same result as was observed in the SVM-based class prediction, with the same tumor sample Y-GC-01-049 being incorrectly predicted as a normal tissue in the test set. This suggests that the current results are not due to a bias originating from the use of a specific statistical algorithm.
Elucidating the molecular-level differences between normal and tumor tissues, as we have done in this report, may not have much clinical applicability. However, it is essential to the understanding of gastric cancer at a molecular level, which can be useful in the development of therapeutic reagent in the long run. The 92 genes, in Fig. 1 and detailed in Table 1 , represent diverse molecular functions including protease inhibitor, tumor suppressor and transcription factors and represent molecular pathways such as focal adhesion (THBS2, PDGFD, MAPK1, COL1A2, COL6A3 and FN1), transforming growth factor-beta (TGF-β) signaling (THBS2, MAPK1 and INHBA). These are major molecular pathways influencing their effect on diverse cellular processes including cell growth, cell differentiation and cell death. To study some of the potential genes for their biochemical roles in the development of gastric cancer, their expression patterns in the gastric cancer cell lines need to be examined. Currently gene expression profiling for the all the available gastric cancer cells is underway. We used class prediction algorithm as a way of selecting for the genes differentially expressed between normal and tumor tissues from gastric cancer. Prediction of the unknown samples was performed to minimize the false positives, rather than for diagnosis purposes. Clinically, diagnosis of normal and/or tumor tissues originated from gastric cancer patients does not require the massive expression profiling studies as we have presented here. However, information on gene expression changes between the two tissue groups would be essential to understand this disease at a molecular level.
